Gina Zeidman, APRN
Women's Health · Gainesville, GANPI 1518337708
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,323 of the $1,475 with a category attached, or 89.7%. 17 manufacturers reported payments, led by AbbVie at 33.7% of the total.
Across 80 payments — averaging $18.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$497
- Millicent US Inc$176
- Bayer$162
- Astellas Pharma US Inc$142
- Mayne Pharma Commercial LLC$70
- Organon$68
- plus $358 from 11 others
What the payments were for
- Food & beverage$1,32390%
- Education$15110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 27 | $497 |
| Millicent US Inc | 6 | $176 |
| Bayer | 9 | $162 |
| Astellas Pharma US Inc | 6 | $142 |
| Mayne Pharma Commercial LLC | 8 | $70 |
| Organon | 3 | $68 |
| Myovant Sciences Inc. | 4 | $62 |
| Exeltis, USA Inc. | 3 | $57 |
| Daiichi Sankyo Inc. | 3 | $53 |
| Optumhealth Care Solutions, LLC | 2 | $53 |
| Evofem Biosciences, Inc. | 3 | $27 |
| Agile Therapeutics, Inc. | 1 | $23 |
| AstraZeneca | 1 | $18 |
| Olympus America Inc. | 1 | $17 |
| Dexcom, Inc. | 1 | $17 |
| Hologic Sales And Service, LLC | 1 | $17 |
| Mylan Pharmaceuticals Inc. | 1 | $13 |
How this compares
$1,475 in reported general payments places this provider in the 80th percentile of 247 women's health providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 36 | $3,327 |
| ValacyclovirValacyclovir Hcl | 25 | $223 |
| Norethindrone | 12 | $162 |
Paid to pharmacies, not to this prescriber.
Other women's health in Gainesville
- Jennifer GrizzleGainesville$1K
- Sherri SellersSavannah$94K
- Jaclyn PiastaMarietta$8K
- Angela HurstMoultrie$5K
- Laurie RayAtlanta$5K
- Heather Thomas-OsuntokunAtlanta$3K
- Ania KirollosChamblee$3K
- Geneva RecordRinggold$3K
- Katie SellsSnellville$3K
- Susan AbbottAtlanta$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.